Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Applied VR gains FDA breakthrough device nod

October 22, 2020 By Sean Whooley

AppliedVR announced that it received FDA breakthrough device designation for its fibromyalgia and lower back pain treatment.

Los Angeles-based AppliedVR’s EaseVRx product is designed to treat treatment-resistant fibromyalgia and chronic intractable lower back pain. With the breakthrough nod, EaseVRx is now one of the first virtual reality (VR) digital therapeutics to earn that designation for treating conditions related to chronic pain, according to a news release.

AppliedVR completed a randomized, controlled trial to evaluate VR-based therapy for chronic pain self-management, reporting results that showed the self-administered, skills-based VR treatment program for chronic pain was feasible and scalable, plus it was effective at improving on multiple outcomes.

EaseVRx helps patients learn self-management skills based on cognitive behavioral therapy (CBT) principles and other behavioral methods. The program, designed by AppliedVR in partnership with top pain experts and researchers, seeks to improve self-regulation of cognitive, emotional and physiological responses to stress and pain.

“AppliedVR is the most evidence-backed VR platform on the market, and today’s FDA designation demonstrates that health experts across the spectrum recognize the therapeutic potential of VR as a viable treatment for pain,” AppliedVR CEO & co-founder Matthew Stoudt said in the release. “Now, with the COVID-19 pandemic severely disrupting Americans’ ability to get in-person care safely, we’re looking forward to getting EaseVRx into the hands of people suffering from pain. Providers believe in it, patients want it, and payers are coming around to it.”

The company is currently engaged in multiple trials for improving care across underserved populations, while it is also advancing two clinical trials to study VR as an opioid-sparing tool for acute and chronic pain. The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), recently awarded grants worth $2.9 million to fund those trials.

Related Articles Read More >

A portrait of Fictiv co-founder and CEO Dave Evans
Manufacturing matchmaker Fictiv raises $100M for supply chain push
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
Zimmer Biomet OptiVu Surgical Demo
Zimmer Biomet introduces OptiVu mixed reality platform, demos new ZBEdge offerings
OpticSurg Vision Beyond
OpticSurg launches AR system to connect frontline workers with remote clinicians

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech